v3.26.1
Shareholders' Equity
 3 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders’ Equity
Stock-Based Compensation
The Company has non-qualified stock options and restricted stock units (RSUs) outstanding under its equity compensation plans. The Company recognized stock-based compensation expense in its Consolidated Financial Statements in the three months ended March 31, 2026 and 2025, respectively, as follows: 
Three Months Ended March 31,
 20262025
Stock-based compensation expense$14,496 $14,138 
Less: Deferred tax benefit(2,410)(2,623)
Stock-based compensation expense, net of tax$12,086 $11,515 
As of March 31, 2026, there was approximately $97,255 of unrecognized compensation cost remaining related to unvested employee stock options and restricted stock units that management expects will vest and is being amortized.
The total intrinsic value of options exercised during the three months ended March 31, 2026 was $16,733. The total options exercisable as of March 31, 2026 had an intrinsic value of $149,914. The total intrinsic value for options exercisable is calculated as the difference between the market value of the Company’s common stock as of March 31, 2026 and the weighted average exercise price of the options. The market value of the Company’s common stock as of March 31, 2026 was $78.47 as reported by the Nasdaq Stock Market, LLC. The weighted average exercise price of the options exercisable as of March 31, 2026 was $59.22. Total options that were outstanding as of March 31, 2026 were 13,069,000. Total options that were exercisable as of March 31, 2026 were 7,788,000.
Common Stock Buyback
The Company’s Board of Directors, under multiple authorizations, has authorized the repurchase of common stock on the open market or through private transactions. The Company purchased 2,554,000 shares at a total cost of $208,292 during the three months ended March 31, 2026, which reduced the total shares outstanding of common stock. The cost of stock purchases during the period includes the cost of excise taxes applicable to stock repurchases and certain transactions that settled in the following quarter. As of March 31, 2026, the Company had approximately $495,115 of authorization remaining for the purchase of common stock under the program.
The Company immediately retires its common stock when purchased. Upon retirement, the Company reduces Capital in excess of par value for the average capital per share outstanding and the remainder is charged against Retained earnings. If the Company reduces its Retained earnings to zero, any subsequent purchases of common stock will be charged entirely to Capital in excess of par value.